Bowman and Brooke was recognized for the eighth time as a Law360 Product Liability Practice Group of the Year for its "versatility" and "long-established reputation as a defense leader."
Bowman and Brooke was ranked by Chambers USA for the seventh consecutive year in the Nationwide Product Liability & Mass Tort category, noting the firm "[i]s unsurpassed in that field." (2018)
Bowman and Brooke attorneys are leaders in their fields, called upon by industry organizations and the media to provide insights on legal trends and developments.
On January 21, 2014, the U.S. Court of Appeals for the Sixth Circuit ruled that manufacturers and sellers of "combination products"—that is, products which have attributes of both pharmaceuticals and medical devices—are not statutorily immune from liability under Michigan's Tort Reform statute. In an article for Law360, Partners Kim Schmid and Jeffrey Gorcyca discuss the ramifications of the decision.
Read the Law360 article.
Recognized for the eleventh consecutive year in “Product liability, mass tort and class action: pharmaceuticals and medical devices - defense.”